Kalin Katherine Bach

SELLAS Life Sciences Group, Inc. · Director

Kalin Katherine Bach is listed in filings as Director at SELLAS Life Sciences Group, Inc.. This profile follows SEC Form 4 activity through Jan 9, 2026, including purchase activity. Recent filings connect the profile to SELLAS Life Sciences Group, Inc. (SLS). The current snapshot covers public activity from Jan 14, 2025 to Jan 9, 2026. Reported amounts are shown as $100.8K to $17.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Latest Trades

CompanyValueActionPriceLast Price
SELLAS Life Sciences Group, Inc.SLS$101k63.4k sharesBuyNov 19, 2025$1.59$13.43